Surgical removal of the tumor is considered the basis for curing gastric cancer. However, 40% of patients who have undergone surgery suffer a relapse within two years. A research team led by MedUni Vienna has now investigated ...
Jul 30, 2024
0
2
A new paper published in the journal Proceedings of the National Academy of Sciences shows how an amino acid may hold the secrets of oral cancers.
Jul 30, 2024
0
57
A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance. The design and preclinical evaluation ...
Jul 29, 2024
0
51
A new University of Kentucky Markey Cancer Center study reveals that many people with cancer in the U.S. do not have equal access to facilities that offer an advanced form of radiation treatment.
Jul 29, 2024
0
10
Many people with stage II or III colon cancer receive additional, or adjuvant, chemotherapy following surgery. However, clinical trials have shown that this treatment doesn't improve the chances of survival for every patient. ...
Jul 27, 2024
0
69
More and more studies show that men face risks of cancer from BRCA1 and BRCA2 genetic mutations that are most often associated with breast and ovarian cancers in women.
Jul 26, 2024
0
23
Northwestern Medicine scientists have discovered that mitochondria are not necessary for the proliferation of specialized immune cells in the central nervous system, but do help those cells respond to demyelinating injuries, ...
Jul 26, 2024
0
73
University of Toronto researchers have identified two genes that play a critical role in tumor growth in the pancreas—findings that have significant implications for understanding and treating pancreatic cancer.
Jul 25, 2024
0
23
Scientists have discovered that electrical currents may make natural killer (NK) cells—our very own cancer-killing immune cells—even better killers, which could have significant implications for treating some cancers.
Jul 25, 2024
0
23
Researchers at UNC Lineberger Comprehensive Cancer Center and colleagues have determined that a specific type of immune cell—type II innate lymphoid cells (ILC2s)—can change its characteristics and functions after a cancer ...
Jul 25, 2024
0
15
